Nara Organics has recalled all Whole Milk Organic Infant Formula sold in the United States after three infants developed botulism and were hospitalized. Federal officials said no deaths have been reported and no tested lots have been positive for Clostridium botulinum.
Posts tagged as “the Food and Drug Administration”
The FDA has approved bemotrizinol, the first new sunscreen ingredient for the U.S. market in more than two decades. The broad-spectrum UV filter has been used for years in Europe and other countries and is expected in U.S. products by year’s end.
K.C. Pharmaceuticals recalls over 3 million eye drop bottles sold at major retailers due to sterility concerns. The FDA classifies the recall as Class II, with no reported injuries so far.
A recent CDC report reveals a significant increase in autism spectrum disorder prevalence among U.S. children, with diagnoses rising from one in 54 in 2016 to one in 31 by 2022. The report highlights variations in autism rates across states, emphasizing the disorder's complexity and the necessity for further research. Despite Robert F. Kennedy Jr.'s pledge to identify autism's cause by September, experts express skepticism due to the intricate nature of autism research, underscoring the need for continued public health efforts and support for affected families.
Health officials and medical professionals have reaffirmed the safety and efficacy of the measles vaccine amid a rise in cases across the United States, with over 700 cases reported nationwide, including more than 500 in Texas. Despite controversy sparked by Health and Human Services Secretary Robert F. Kennedy Jr.'s claims about the vaccine's safety testing and duration of protection, he acknowledges that vaccination is the most effective method to prevent measles transmission. As measles is highly contagious and can lead to severe health complications, federal health agencies continue to advocate for widespread vaccination to protect public health.
The Department of Health and Human Services (HHS) has initiated significant layoffs, aiming to reduce its workforce by 20,000 positions as part of the Trump administration's strategy to decrease government size. Notably, the National Institute of Occupational Safety and Health (NIOSH) will experience substantial cuts, losing around 873 staff members, which constitutes at least two-thirds of its workforce. This downsizing, overseen by Health and Human Services Secretary Robert F. Kennedy Jr. and Elon Musk's Department of Government Efficiency, will impact several key agencies, raising concerns about their ability to maintain public health and safety services.
The FDA is considering the approval of exa-cel, a new drug developed by Vertex Pharmaceuticals that could be the first cure available for many patients with sickle cell disease. The illness affects an estimated 100,000 people in the U.S., mostly Black, and causes anemia, pain, and organ damage. If approved, exa-cel would be the first drug to use the groundbreaking gene-editing tool CRISPR and provide a universally available, potentially curative option for individuals with sickle cell. The FDA is expected to make a decision on the drug in the coming months.
The FDA has issued a warning about the potential dangers of probiotics for preterm infants, citing more than two dozen adverse events linked to the products since 2018. The agency is investigating whether probiotics have contributed to other cases in babies and has sent a letter to health care providers about the dangers of these products. Parents and caregivers are urged to talk to their health care provider before giving probiotics to preterm infants and to report any adverse events to the FDA's MedWatch Adverse Event Reporting program.